EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon

Dalal Nour, Mohamad Bachar Ismail iD, Marwan Osman iD, Rayane Rafei iD, Dalal Kasir, Fouad Dabboussi, Philippe Colson, Monzer Hamze iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0302579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Dalal Nour und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire Microbiologie Santé et Environnement (LMSE), Doctoral School of Science & Technology, Faculty of Public Health, Lebanese University, Trip…. Hauptthemen laut MEDLINE: Antibodies, Viral, Breakthrough Infections, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Université Libanaise, Sanabel Nour association, Fondation Mérieux.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since March 2020, the COVID-19 pandemic has swiftly propagated, triggering a competitive race among medical firms to forge vaccines that thwart the infection. Lebanon initiated its vaccination campaign on February 14, 2021. Despite numerous studies conducted to elucidate the characteristics of immune responses elicited by vaccination, the topic remains unclear. Here, we aimed to track the progression of anti-spike SARS-CoV-2 antibody titers at two-time points (T1: shortly after the second vaccination dose, T2: six months later) within a cohort of 201 adults who received Pfizer-BioNTech (BNT162b2), AstraZeneca, or Sputnik V vaccines in North Lebanon. Blood specimens were obtained from participants, and antibody titers against SARS-CoV-2 were quantified through the Elecsys-Anti-SARS-CoV-2 S assay (Roche Diagnostics, Switzerland). We used univariate analysis and multivariable logistic regression models to predict determinants influencing the decline in immune response and the occurrence of breakthrough infections among vaccinated patients. Among the 201 participants, 141 exhibited unchanging levels of antibody titers between the two sample collections, 55 displayed waning antibody titers, and only five participants demonstrated heightened antibody levels. Notably, age emerged as the sole variable significantly linked to the waning immune response. Moreover, the BNT162b2 vaccine exhibited significantly higher efficacy concerning the occurrence of breakthrough infections when compared with the AstraZeneca vaccine. Overall, our study reflected the immune status of a sample of vaccinated adults in North Lebanon. Further studies on a larger scale are needed at the national level to follow the immune response after vaccination, especially after the addition of the third vaccination dose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralBreakthrough InfectionsCOVID-19SARS-CoV-2AdultAgedFemaleHumansMaleMiddle AgedYoung AdultBNT162 VaccineCOVID-19 VaccinesLebanonSpike Glycoprotein, CoronavirusVaccination

Substanzen

Antibodies, ViralBNT162 VaccineCOVID-19 VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Laboratoire Microbiologie Santé et Environnement (LMSE), Doctoral School of Science & Technology, Faculty of Public Health, Lebanese University, Tripoli, Lebanon.
  • Aix-Marseille Univ., Institut de Recherche pour le Développement (IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Marseille, France.
  • Faculty of Sciences, Lebanese University, Tripoli, Lebanon.
  • Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, United States of America.
  • IHU Méditerranée Infection, Marseille, France.
  • Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France.

ORCID-Profile: Mohamad Bachar Ismail, Marwan Osman, Rayane Rafei, Monzer Hamze

Förderung

  • Université Libanaise
  • Sanabel Nour association
  • Fondation Mérieux
  • GABRIEL network

Zitieren

APA

Nour, D., Ismail, M. B., Osman, M., Rafei, R., Kasir, D., Dabboussi, F., Colson, P., & Hamze, M. (2024). Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon. PLOS ONE. https://doi.org/10.1371/journal.pone.0302579

Vancouver

Nour D, Ismail MB, Osman M, Rafei R, Kasir D, Dabboussi F, et al. Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon. PLOS ONE. 2024. doi:10.1371/journal.pone.0302579

BibTeX
@article{Nour2024,
  author = {Nour, Dalal and Ismail, Mohamad Bachar and Osman, Marwan and Rafei, Rayane and Kasir, Dalal and Dabboussi, Fouad and Colson, Philippe and Hamze, Monzer},
  title = {Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0302579}
}
Kostenlos starten →